Ciprofloxacin-induced hemorrhagic vasculitis.
Ciprofloxacin-induced hemorrhagic vasculitis is a rare side effect. It has only been described in 10 case reports since 1989. However, recently we were confronted with two cases within 1 month. In one patient the vasculitis resolved after termination of the ciprofloxacin therapy; in the other patient the ciprofloxacin-induced hemorrhagic vasculitis was superimposed on a severe forefoot infection, leading to progressive gangrene and a below-knee amputation. Ciprofloxacin is among the standard treatments for infected ischemic ulcers; in the rare case of ciprofloxacin-induced hemorrhagic vasculitis, it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment. The intention of this case report is to raise awareness for anyone prescribing ciprofloxacin as treatment for infected diabetic and ischemic ulcers.
van den Berg
Frank P
FP
Department of Surgery, Atrium Medical Center Parkstad, Heerlen, The Netherlands. j.teijink@atriummc.nl
Wagenvoort
J H T
JH
van der Kleij
A M J
AM
Teijink
Joep A W
JA
D000368:Aged; D000369:Aged, 80 and over; D000671:Amputation, Surgical; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002939:Ciprofloxacin / Q000009:adverse effects*; D017719:Diabetic Foot / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D016972:Enterobacter cloacae / Q000302:isolation & purification; D005260:Female; D005734:Gangrene; D006801:Humans; D011695:IgA Vasculitis / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D007866:Leg / Q000473:pathology / Q000601:surgery; D008297:Male; D011513:Proteus mirabilis / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000302:isolation & purification
D000890:Anti-Infective Agents; D002939:Ciprofloxacin